Industry Insights Logo

The Mpox Outbreak: What a Swift Response Looks Like

Asha Doucet headshot on light blue background

SPONSORED CONTENT

The monkeypox (renamed mpox by the World Health Organization) outbreak took the world by storm in early May of 2022 on the heels of the COVID-19 pandemic. The AIDS Healthcare Foundation (AHF) was among the first public health organizations to sound the

Read More »
Industry Insights Logo

Improve Quality Outcomes with ACOs and 340B

SPONSORED CONTENT

Increasingly, participants in Accountable Care Organizations (ACOs) are discovering and benefiting from the 340B drug discount program. Unlike the historic fee-for-service healthcare models, ACOs are rewarded for outcomes that are better aligned with value-based population health, including improved patient care outcomes, an

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Rhodie Smith, Vice President, Contract Pharmacy Sales, RxStrategies

Rhodie Smith headshot
Rhodie Smith

Q: Where did you grow up?

I grew up in Boksburg, a small town outside of Johannesburg, South Africa.

Q: Where did you go to college/graduate school?

I studied at University of Johannesburg, University of the Free State, South Africa and University of Georgia.

Q: What are your favorites?

Food:  Meat and of course any kind

Movie:

Read More »
Industry Insights Logo

Visante’s Top 10 Issues in Pharmacy in 2023 for Health Care Providers

SPONSORED CONTENT

We are pleased to again bring you Visante’s Top 10 issues in pharmacy for 2023. For 2022, our Top 10 items (Pharmacy Org Structure, 340B Program, Vertical Integration & Marketplace Restrictions, Drug Prices & Supply Chain, Infusion Services, Drug Shortages, Pandemic, Economy, Election, Social Justice)

Read More »
Industry Insights Logo

340B Pricing: Navigating Pharmacy Discount Programs to Benefit Your Entity & Patients

Jim Donnelly, Hudson Headwaters 340B

SPONSORED CONTENT

The 340B statute was written as a drug pricing program that outlines specifically what manufacturers are required to charge qualified covered entities for their drugs based on a defined formula. The intent of the 340B program is to help

Read More »

340B INDUSTRY LEADER SPOTLIGHT

William von Oehsen, Principal, Powers Law Firm

William "Bill" von Oehsen, Principal, Powers Law Firm featured image
William "Bill" von Oehsen, Principal, Powers Law Firm
William von Oehsen

Q: Where did you grow up?

Central New Jersey

Q: Where did you go to college/graduate school?

Princeton (AB), Harvard (MTS), Georgetown (JD)

Q: What are your favorites?

Food: Charcuterie

Movie: Monty Python and the Holy Grail

Musicians: Pink Floyd and other “prog” bands from the 70s and 80s

Destination:  Vermont

Q: What do you

Read More »
Industry Insights Logo

Top Referral Specialties And Medications Driving 340B Savings

Don Holladay and Stephanie Caiazzo of Cloudmed

SPONSORED CONTENT

Cloudmed routinely analyzes aggregate data to identify 340B program trends and patterns that can provide useful client insights regarding referral prescriptions. Our 340B team observed two calendar years of data across more than 230 covered entity sites to understand which drugs, therapeutic classes, and medical specialties account for the

Read More »
Industry Insights Logo

The Time to Step Up Is Now: Advocating for 340B

silhouettes of colorful hands

SPONSORED CONTENT

Pop Quiz: Which of these statements are false?

  1. The United States spends more on health care than any other developed nation. But when compared to 11 other high-income countries, the U.S. ranks last for access to care, health equity, and health outcomes. Case in
Read More »
Industry Insights Logo

Webinar: 340B Judicial, Legislative and Regulatory Developments

SPONSORED CONTENT

Join Verity Solutions for our next Lunch & Learn webinar session on Thursday, December 15 at 1:30PM ET as we welcome 340B Report Editor in Chief Tom Mirga for a discussion about new and ongoing 340B developments on the judicial, legislative, and regulatory

Read More »
Industry Insights Logo

The Importance of Strong Partnerships to Enhance Patient Care, Reduce Costs and Maximize Compliance

ShaiAnn Howard, 340B Director, Alliance Rx Walgreens Pharmacy

SPONSORED CONTENT

340B providers are facing an unprecedented number of challenges. 340B program managers are forced to react to these changes every day. Having access to clear and understandable data and developing strong relationships with partners in the 340B supply chain are critical to running an effective program. 340B

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live